SINGH PHARMA LIMITED

Company Registration Number:
06071342 (England and Wales)

Unaudited abridged accounts for the year ended 23 February 2023

Period of accounts

Start date: 24 February 2022

End date: 23 February 2023

SINGH PHARMA LIMITED

Contents of the Financial Statements

for the Period Ended 23 February 2023

Balance sheet
Notes

SINGH PHARMA LIMITED

Balance sheet

As at 23 February 2023


Notes

2023

2022


£

£
Fixed assets
Intangible assets: 3 500,000 0
Tangible assets: 4 10,376 12,208
Investments: 5 39,920 39,920
Total fixed assets: 550,296 52,128
Current assets
Stocks: 71,045 56,177
Debtors: 6 732,551 712,736
Cash at bank and in hand: 262,258 704,204
Total current assets: 1,065,854 1,473,117
Creditors: amounts falling due within one year: 7 (769,057) (768,734)
Net current assets (liabilities): 296,797 704,383
Total assets less current liabilities: 847,093 756,511
Total net assets (liabilities): 847,093 756,511
Capital and reserves
Called up share capital: 4 4
Profit and loss account: 847,089 756,507
Shareholders funds: 847,093 756,511

The notes form part of these financial statements

SINGH PHARMA LIMITED

Balance sheet statements

For the year ending 23 February 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 20 November 2023
and signed on behalf of the board by:

Name: G Singh
Status: Director

The notes form part of these financial statements

SINGH PHARMA LIMITED

Notes to the Financial Statements

for the Period Ended 23 February 2023

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

SINGH PHARMA LIMITED

Notes to the Financial Statements

for the Period Ended 23 February 2023

2. Employees

2023 2022
Average number of employees during the period 10 9

SINGH PHARMA LIMITED

Notes to the Financial Statements

for the Period Ended 23 February 2023

3. Intangible Assets

Total
Cost £
At 24 February 2022 0
Additions 500,000
Disposals 0
Revaluations 0
Transfers 0
At 23 February 2023 500,000
Amortisation
At 24 February 2022 0
Charge for year 0
On disposals 0
Other adjustments 0
At 23 February 2023 0
Net book value
At 23 February 2023 500,000
At 23 February 2022 0

SINGH PHARMA LIMITED

Notes to the Financial Statements

for the Period Ended 23 February 2023

4. Tangible Assets

Total
Cost £
At 24 February 2022 49,211
Additions 0
Disposals 0
Revaluations 0
Transfers 0
At 23 February 2023 49,211
Depreciation
At 24 February 2022 37,003
Charge for year 1,832
On disposals 0
Other adjustments 0
At 23 February 2023 38,835
Net book value
At 23 February 2023 10,376
At 23 February 2022 12,208

SINGH PHARMA LIMITED

Notes to the Financial Statements

for the Period Ended 23 February 2023

5. Fixed investments

Cost at 23/02/22 = £39,920Cost at 23/02/23 = £39,920

SINGH PHARMA LIMITED

Notes to the Financial Statements

for the Period Ended 23 February 2023

6. Debtors

2023 2022
££
Debtors due after more than one year: 732,551 712,736

SINGH PHARMA LIMITED

Notes to the Financial Statements

for the Period Ended 23 February 2023

7. Creditors: amounts falling due within one year note

Creditors at 23/02/22 = £768,734Creditors at 23/02/23 = £769,057